Literature DB >> 11390261

Magnetic resonance angiography at 0.3 T using MS-325.

K M Lahti1, R B Lauffer, T Chan, R M Weisskoff.   

Abstract

Preliminary results on MS-325 versus ProHance enhanced magnetic resonance angiography (MRA) at low field strength in a rabbit model are reported. MS-325-enhanced images were acquired in vivo and compared with pre-contrast as well as conventional contrast-enhanced images. Visual image quality observations correlated with measurements of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR). While published in vitro data show 7-fold greater relaxivity for MS-325 compared with conventional contrast agents, we observed an even greater effect here due, presumably, to better matching of the longer vascular lifetime with longer scan time in this study. In addition, overall vessel clarity improved significantly throughout all the phases of the experiment in MS-325-enhanced images when compared with conventional contrast-enhanced images.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390261     DOI: 10.1007/bf02668087

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  9 in total

Review 1.  Orthopedic and interventional applications at low field MRI with horizontally open configuration. A review.

Authors:  S K Koskinen; R K Parkkola; J Karhu; M E Komu; M J Kormano
Journal:  Radiologe       Date:  1997-10       Impact factor: 0.635

2.  Tissue relaxation time: in vivo field dependence.

Authors:  G A Johnson; R J Herfkens; M A Brown
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

3.  MS-325: albumin-targeted contrast agent for MR angiography.

Authors:  R B Lauffer; D J Parmelee; S U Dunham; H S Ouellet; R P Dolan; S Witte; T J McMurry; R C Walovitch
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

4.  Steady-state and dynamic MR angiography with MS-325: initial experience in humans.

Authors:  T M Grist; F R Korosec; D C Peters; S Witte; R C Walovitch; R P Dolan; W E Bridson; E K Yucel; C A Mistretta
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

5.  Magnetic field dependence of 1/T1 of protons in tissue.

Authors:  S H Koenig; R D Brown; D Adams; D Emerson; C G Harrison
Journal:  Invest Radiol       Date:  1984 Mar-Apr       Impact factor: 6.016

Review 6.  New MR imaging contrast agents.

Authors:  J P Earls; D A Bluemke
Journal:  Magn Reson Imaging Clin N Am       Date:  1999-05       Impact factor: 2.266

7.  Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.

Authors:  S E Clarke; H J Weinmann; E Dai; A R Lucas; B K Rutt
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

8.  Intracranial hematomas studied by MR imaging at 0.17 and 0.02 T.

Authors:  J T Sipponen; R E Sepponen; J I Tanttu; A Sivula
Journal:  J Comput Assist Tomogr       Date:  1985 Jul-Aug       Impact factor: 1.826

9.  1/T1 NMRD profiles of solutions of Mn2+ and Gd3+ protein-chelate conjugates.

Authors:  R B Lauffer; T J Brady; R D Brown; C Baglin; S H Koenig
Journal:  Magn Reson Med       Date:  1986-08       Impact factor: 4.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.